Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NLS Pharmaceutics AG

    NASDAQ: NLSP · Real-Time Price · USD
    2.63
    -0.05 (-1.87%)
    At close: Aug 21, 2025, 10:03 AM

    NLS Pharmaceutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    PE Ratio
    		 -40.43 -41.82K -55.16 -43.82 -10.8 -22.3 -75.5
    PEG Ratio
    		 0.40 1.41K 1.78 0.95 -1.35 -1.17 -3.21
    PS Ratio
    		 n/a n/a n/a n/a n/a n/a n/a
    PB Ratio
    		 -35.53 -86.34 -391.84 419.67 -92.37 1.21K 327.21
    P/FCF Ratio
    		 -215.14 -319.41K -230.21 -221.58 -48.7 -125.7 -142.36
    P/OCF Ratio
    		 -215.14 -319.41K -230.21 -221.58 -48.7 -125.86 -142.84
    OCF/S Ratio
    		 n/a n/a n/a n/a n/a n/a n/a
    Debt / Equity Ratio
    		 -0.18 -0.18 n/a n/a -0.09 n/a n/a
    Quick Ratio
    		 0.15 0.23 0.59 2.76 0.61 2.40 6.95
    Current Ratio
    		 0.15 0.23 0.58 2.75 0.59 2.38 6.91
    Asset Turnover
    		 n/a n/a n/a n/a n/a n/a n/a
    Interest Coverage
    		 n/a -0.03 -58.52K -74.1 -946.41 n/a -66.67
    Return on Equity
    		 0.22 n/a 1.78 -2.39 2.14 -13.54 -1.08
    Return on Assets
    		 -1.71 n/a -3.35 -0.85 -4.2 -1.27 -0.56
    Return on Invested Capital
    		 0.43 n/a 4.65 -1.15 8.70 -2.18 -0.64
    Dividend Yield
    		 n/a n/a n/a n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist